Nureca Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
May 23, 2023 at 10:32 am EDT
Share
Nureca Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 212.26 million compared to INR 410.49 million a year ago. Revenue was INR 233.74 million compared to INR 427.59 million a year ago. Net loss was INR 15.3 million compared to INR 14.04 million a year ago. Basic loss per share from continuing operations was INR 1.53 compared to INR 1.4 a year ago.
For the full year, sales was INR 1,113.23 million compared to INR 2,555.48 million a year ago. Revenue was INR 1,184.28 million compared to INR 2,632.43 million a year ago. Net loss was INR 82.5 million compared to net income of INR 449.6 million a year ago. Basic loss per share from continuing operations was INR 8.25 compared to basic earnings per share from continuing operations of INR 44.96 a year ago.
Nureca Limited is an India-based company, which is engaged in the business of home healthcare and wellness products. The main products/services that the Company manufactures include chronic disease products, orthopedic products, mother and child products, nutrition supplements, lifestyle products, and connected devices. Its chronic disease products include nebulizers, BP monitors, finger pulse oximeters, glucose meters and thermometers. Its orthopedic products include wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers. Its mother and babycare products include baby feeding, carry cots, baby skincare, nebulizers and bottle warmers and steamers. Its nutrition supplements include supplements and weight management products. Its lifestyle products include humidifiers and steamers, personal scales, massagers, fitness tracking, and dental and personal care. The Company's products are offered through its brands, such as Dr Trust, Dr Physio, and Trumom.
NURECA LIMITED 
